Scholarlink

<p>MRI has traditionally been employed to rule out alternative diagnoses in unilateral acute vestibular syndrome (UAVS), but delayed 3D-FLAIR sequences offer the potential for imaging to contribute to both diagnosis and management. This study aimed to assess abnormalities on delayed 3D-FLAIR MRI in UAVS patients and correlate these findings with clinical outcomes. A retrospective multicenter study was conducted between January 2018 and May 2024 at a university hospital and a private vestibular clinic, representing a diverse clinical setting. It included 92 patients with UAVS (47 women, 45 men; mean age 50.6&#xa0;years) diagnosed according to Bárány Society guidelines, with acute vertigo lasting at least 24&#xa0;h, spontaneous horizontal-rotatory nystagmus, and a reduced vestibulo-ocular reflex (VOR) on the affected side, without auditory or neurological symptoms. The MRI findings were blindly assessed to identify potential blood-labyrinth barrier (BLB) impairment, nerve enhancement, or canal fibrosis. These imaging abnormalities were then correlated with initial and follow-up video head impulse test (vHIT) results. BLB impairment was found in 63% of patients and canal fibrosis in 14.1%, with no nerve enhancement detected. BLB impairment significantly correlated with initial VOR deficits and was linked to poorer vHIT recovery, suggesting its role in predicting persistent vestibular dysfunction. These findings suggest that delayed 3D-FLAIR MRI can identify biomarkers, particularly BLB impairment, that are predictive of vestibular recovery, highlighting MRI’s role in guiding UAVS treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Delayed 3D-FLAIR MRI and vestibular recovery in unilateral acute vestibular syndrome

  • 期刊论文

  • 发表日期：

    2025年2月11日

查看全文
  • Clémence Vaudelin,
  • Jean-Noël Vallée,
  • Charlotte Hautefort,
  • Cassandre Djian,
  • Rodolphe Vallée,
  • Michel Toupet,
  • Michael Eliezer

摘要

MRI has traditionally been employed to rule out alternative diagnoses in unilateral acute vestibular syndrome (UAVS), but delayed 3D-FLAIR sequences offer the potential for imaging to contribute to both diagnosis and management. This study aimed to assess abnormalities on delayed 3D-FLAIR MRI in UAVS patients and correlate these findings with clinical outcomes. A retrospective multicenter study was conducted between January 2018 and May 2024 at a university hospital and a private vestibular clinic, representing a diverse clinical setting. It included 92 patients with UAVS (47 women, 45 men; mean age 50.6 years) diagnosed according to Bárány Society guidelines, with acute vertigo lasting at least 24 h, spontaneous horizontal-rotatory nystagmus, and a reduced vestibulo-ocular reflex (VOR) on the affected side, without auditory or neurological symptoms. The MRI findings were blindly assessed to identify potential blood-labyrinth barrier (BLB) impairment, nerve enhancement, or canal fibrosis. These imaging abnormalities were then correlated with initial and follow-up video head impulse test (vHIT) results. BLB impairment was found in 63% of patients and canal fibrosis in 14.1%, with no nerve enhancement detected. BLB impairment significantly correlated with initial VOR deficits and was linked to poorer vHIT recovery, suggesting its role in predicting persistent vestibular dysfunction. These findings suggest that delayed 3D-FLAIR MRI can identify biomarkers, particularly BLB impairment, that are predictive of vestibular recovery, highlighting MRI’s role in guiding UAVS treatment.